Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
Hematologic Oncology Update
00:00
Case 3: Siltuximab-linked delayed cranial nerve palsy
Dr Lunning presents a myeloma patient who developed delayed facial nerve palsy post‑siltuximab, managed with steroids and IVIG.
Play episode from 49:12
Transcript
